A meta-analysis of inflammatory markers in clinically significant symptoms of depression and anxiety found higher standardized mean differences in the levels of IL-6, IL-17A, IL-12, IL-13, neutrophils, and monocytes, as well as lower levels of lymphocytes in individuals with clinically significant depression. The gene discussed is IL17A; the disease is depressive disorder.